Nodular Lymphocyte-Predominant Hodgkin's Lymphoma
1 clinical trials · Condition
◉ Watch Nodular Lymphocyte-Predominant Hodgkin's Lymphoma
| Record | Firm | Date |
|---|---|---|
| Ibrutinib in Relapsed Nodular Lymphocyte-predominant Hodgkin Lymphoma (NLPHL) (NCT02626884) | University of Cologne | 2016-08-01 |
Track Nodular Lymphocyte-Predominant Hodgkin's Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.